No Data
No Data
Pulike Biological Engineering, Inc. Half-Year Performance Forecast for 2024.
Pulike Biological Engineering, Inc. (603566.SH): Net income in the first half of the year is expected to decrease by 30.03% to 40.40%.
On July 9th, Gelonhui reported that Pulike Biological Engineering, Inc. (603566.SH) announced its performance forecast for the first half of 2024. According to preliminary calculations by the company's finance department, it is expected to achieve a net income of 69 million to 81 million yuan attributable to owners of the parent company in the first half of 2024, a decrease of 34.77 million to 46.77 million yuan compared to the same period last year, a year-on-year decrease of 30.03% to 40.40%. It is expected to achieve a net profit attributable to owners of the parent company after deducting non-recurring gains and losses of 62 million to 74 million yuan in the first half of 2024, a decrease of 4.93 compared to the same period last year.
Pulike Biological Engineering, Inc. (603566.SH) has repurchased a total of 2,504,800 shares of stock.
On July 1, Gelonhui announced that pulike biological engineering,inc. (603566.SH) has repurchased 2.5048 million shares through centralized bidding trading as of June 30, 2024. The repurchased shares accounted for 0.72% of the company's total share capital. The highest repurchase price was 22.48 yuan/share, the lowest was 13.85 yuan/share, and the total amount paid was 40,577,179 yuan (excluding transaction costs).
Pulike Biological Engineering Inc. (603566.SH) plans to distribute 0.4 yuan per share in 2023, with an ex-right date of June 14th.
Pulike Biological Engineering, Inc. (603566.SH) released an announcement for the 2023 annual profit distribution plan: distributing cash dividends per share...
Pulike Biological Engineering, Inc. (603566.SH) has cumulatively spent 25.41 million yuan to repurchase 0.42% of its shares.
On June 3rd, Gelunhui reported that as of May 31, 2024, Pulike Biological Engineering, Inc. (603566.SH) has cumulatively repurchased 1.4492 million shares through centralized bidding trading, accounting for 0.42% of the total share capital of the company. The highest repurchase price was 22.48 yuan/share and the lowest was 15.47 yuan/share. The total amount paid was 25,410,025 yuan (excluding transaction fees).
After Leaping 34% Pulike Biological Engineering, Inc. (SHSE:603566) Shares Are Not Flying Under The Radar
No Data